RaiseTrack

This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: location, two agreeing sources.

Immuno Cancer Biotherapeutics

Immuno Cancer Biotherapeutics reported $75,000 raised in an SEC Form D filed on 2026-10-15. State of the filing: South Dakota.

Industry
Biotechnology
Location
South Dakota

About

Immuno Cancer Biotherapeutics appears in Section 3 of the Raise Track Update of 2026-10-16, which lists new SEC Form D filings. The filing reports $75,000 raised and gives South Dakota as the state. The industry on the filing is Biotechnology. Related persons named on the filing: James Robl (executive officer, director, Canton, South Dakota); Stephen Collins (director, Lake Forest, Illinois). Filing: https://www.sec.gov/Archives/edgar/data/2158173/000215817326000001/0002158173-26-000001-index.htm The offering amount on the form is indefinite. The amount sold is $75,000.

This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.

Funding history

RoundDateAmountLead
Form D 20262026-10-15$75K

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/2158173/000215817326000001/0002158173-26-000001-index.htm
    Type: sec filing. Accessed 2026-10-16.
    SEC Form D for Immuno Cancer Biotherapeutics, Inc. EDGAR filing date 2026-10-15. Signed 2026-10-15. First sale 2026-10-09. Total amount sold $75,000 of an indefinite offering amount. 3 investors already invested. Issuer address city is Canton, South Dakota. Jurisdiction of incorporation is Delaware. Entity type on the form is Corporation. Year of incorporation on the form: 2024. The form does not name the purchasers or a round type. Street addresses are not published. The offering amount on the form is indefinite. The amount sold is $75,000.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-16/
    Type: other verified public source. Accessed 2026-10-16.
    Raise Track Update for 2026-10-16, Section 3. Lists Immuno Cancer Biotherapeutics, state SOUTH DAKOTA, industry Biotechnology, amount raised $75,000.